Established in 1999, Kirovest Pharmaceutical Company S.A.E. is a national Egyptian company built on international standards of quality and manufacturing excellence. With a paid-in capital of EGP 500 million, Kirovest has grown into a leading manufacturer and marketer of animal health and human pharmaceutical products.
From its inception, Kirovest was designed to operate on globally recognized standards of quality and manufacturing excellence. This strong foundation enabled the company to position itself as a trusted national player in the Egyptian pharmaceutical market.
Over the years, Kirovest has expanded its portfolio to include a wide range of essential therapies that address critical healthcare needs…
Today, Kirovest maintains a robust and diverse product portfolio, supported by 150+ new products in registration…
Kirovest’s continuous growth is driven by strategic investments…
To improve healthcare outcomes and enhance patients’ quality of life by providing high-quality, reliable, and accessible pharmaceutical and animal health products.
Established in 1999, Kirovest Pharmaceutical Company S.A.E. is a national Egyptian company built on international standards of quality and manufacturing excellence.